C. Wagenvoort and N. Wagenvoort, Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases, Circulation, vol.42, issue.6, pp.1163-1171, 1970.
DOI : 10.1161/01.CIR.42.6.1163

M. Humbert, N. Morrell, S. Archer, K. Stenmark, M. Maclean et al., Cellular and molecular pathobiology of pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.43, issue.12, pp.13-24, 2004.
DOI : 10.1016/j.jacc.2004.02.029

S. Adnot, Lessons learned from cancer may help in the treatment of pulmonary hypertension, Journal of Clinical Investigation, vol.115, issue.6, pp.1461-1463, 2005.
DOI : 10.1172/JCI25399

S. Eddahibi, N. Hanoun, L. Lanfumey, K. Lesch, B. Raffestin et al., Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene, Journal of Clinical Investigation, vol.105, issue.11, pp.1555-1562, 2000.
DOI : 10.1172/JCI8678

S. Eddahibi, M. Humbert, E. Fadel, B. Raffestin, M. Darmon et al., Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension, Journal of Clinical Investigation, vol.108, issue.8, pp.1141-1150, 2001.
DOI : 10.1172/JCI200112805

E. Marcos, E. Fadel, O. Sanchez, M. Humbert, P. Dartevelle et al., Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension, Circulation Research, vol.94, issue.9, pp.1263-1270, 2004.
DOI : 10.1161/01.RES.0000126847.27660.69

S. Lee, W. Wang, B. Moore, and B. Fanburg, Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture, Circulation Research, vol.68, issue.5, pp.1362-1368, 1991.
DOI : 10.1161/01.RES.68.5.1362

S. Eddahibi, V. Fabre, C. Boni, M. Martres, B. Raffestin et al., Induction of Serotonin Transporter by Hypoxia in Pulmonary Vascular Smooth Muscle Cells : Relationship With the Mitogenic Action of Serotonin, Circulation Research, vol.84, issue.3, pp.329-336, 1999.
DOI : 10.1161/01.RES.84.3.329

C. Guignabert, B. Raffestin, R. Benferhat, R. W. Zadigue, P. Rideau et al., Serotonin Transporter Inhibition Prevents and Reverses Monocrotaline-Induced Pulmonary Hypertension in Rats, Circulation, vol.111, issue.21, pp.2812-2819, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.524926

URL : https://hal.archives-ouvertes.fr/inserm-00499643

S. Eddahibi, S. Adnot, E. Frisdal, M. Levame, M. Hamon et al., Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats, J Pharmacol Exp Ther, vol.297, pp.148-154, 2001.

M. Maclean, G. Deuchar, M. Hicks, I. Morecroft, S. Shen et al., Overexpression of the 5-Hydroxytryptamine Transporter Gene: Effect on Pulmonary Hemodynamics and Hypoxia-Induced Pulmonary Hypertension, Circulation, vol.109, issue.17, pp.2150-2155, 2004.
DOI : 10.1161/01.CIR.0000127375.56172.92

H. Moessler, M. Mericskay, Z. Li, S. Nagl, D. Paulin et al., The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice, Development, vol.122, pp.2415-2425, 1996.

M. Hamon, C. Fattaccini, A. J. Gallissot, M. Martin, P. Gozlan et al., Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties, J Pharmacol Exp Ther, vol.246, pp.745-752, 1988.

S. Archer, E. Souil, A. Dinh-xuan, B. Schremmer, J. Mercier et al., Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes., Journal of Clinical Investigation, vol.101, issue.11, pp.2319-2330, 1998.
DOI : 10.1172/JCI333

Z. Deng, J. Morse, S. Slager, N. Cuervo, K. Moore et al., Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor???II Gene, The American Journal of Human Genetics, vol.67, issue.3, pp.737-744, 2000.
DOI : 10.1086/303059

K. Lane, R. Machado, M. Pauciulo, J. Thomson, J. Phillips et al., Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium, Nat Genet, vol.26, pp.81-84, 2000.

Y. Song, J. Jones, H. Beppu, J. Keaney, . Jr et al., Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice, Circulation, vol.112, issue.4, pp.553-562, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.492488

R. Tuder, C. Cool, M. Geraci, J. Wang, S. Abman et al., Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.159, issue.6, pp.1925-1932, 1999.
DOI : 10.1164/ajrccm.159.6.9804054

B. Christman, C. Mcpherson, J. Newman, G. King, G. Bernard et al., An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension, New England Journal of Medicine, vol.327, issue.2, pp.70-75, 1992.
DOI : 10.1056/NEJM199207093270202

A. Giaid, M. Yanagisawa, D. Langleben, R. Michel, R. Levy et al., Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension, New England Journal of Medicine, vol.328, issue.24, pp.1732-1739, 1993.
DOI : 10.1056/NEJM199306173282402

L. Du, C. Sullivan, D. Chu, A. Cho, M. Kido et al., Signaling Molecules in Nonfamilial Pulmonary Hypertension, New England Journal of Medicine, vol.348, issue.6, pp.500-509, 2003.
DOI : 10.1056/NEJMoa021650

E. Weir, J. Lopez-barneo, K. Buckler, and S. Archer, Acute Oxygen-Sensing Mechanisms, New England Journal of Medicine, vol.353, issue.19, pp.2042-2055, 2005.
DOI : 10.1056/NEJMra050002

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803102

Y. Yu, O. Platoshyn, J. Zhang, S. Krick, Y. Zhao et al., c-Jun Decreases Voltage-Gated K+ Channel Activity in Pulmonary Artery Smooth Muscle Cells, Circulation, vol.104, issue.13, pp.1557-1563, 2001.
DOI : 10.1161/hc3801.095662

J. Post, J. Hume, S. Archer, and E. Weir, Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction, Am J Physiol, vol.262, pp.882-890, 1992.

X. Yuan, J. Wang, M. Juhaszova, S. Gaine, and L. Rubin, Attenuated K+ channel gene transcription in primary pulmonary hypertension, The Lancet, vol.351, issue.9104, pp.726-727, 1998.
DOI : 10.1016/S0140-6736(05)78495-6

M. Geraci, M. Moore, T. Gesell, M. Yeager, L. Alger et al., Gene Expression Patterns in the Lungs of Patients With Primary Pulmonary Hypertension : A Gene Microarray Analysis, Circulation Research, vol.88, issue.6, pp.555-562, 2001.
DOI : 10.1161/01.RES.88.6.555

Y. Liu and B. Fanburg, Serotonin-Induced Growth of Pulmonary Artery Smooth Muscle Requires Activation of Phosphatidylinositol 3-Kinase/Serine-Threonine Protein Kinase B/Mammalian Target of Rapamycin/p70 Ribosomal S6 Kinase 1, American Journal of Respiratory Cell and Molecular Biology, vol.34, issue.2, pp.182-191, 2006.
DOI : 10.1165/rcmb.2005-0163OC

A. Cross, L. Henderson, O. Jones, M. Delpiano, J. Hentschel et al., sensor protein in the rat carotid body, Biochemical Journal, vol.272, issue.3, pp.743-747, 1990.
DOI : 10.1042/bj2720743

N. Chandel, E. Maltepe, E. Goldwasser, C. Mathieu, M. Simon et al., Mitochondrial reactive oxygen species trigger hypoxia-induced transcription, Proceedings of the National Academy of Sciences, vol.95, issue.20, pp.11715-11720, 1998.
DOI : 10.1073/pnas.95.20.11715

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC21706

S. Eddahibi, A. Chaouat, N. Morrell, E. Fadel, C. Fuhrman et al., Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease, Circulation, vol.108, issue.15, pp.1839-1844, 2003.
DOI : 10.1161/01.CIR.0000091409.53101.E8